HealthEU-Startupsabout 2 hours ago
Alchemab raises €29.3M from British Business Bank
4 min read
Alchemab Therapeutics, a London-based clinical-stage BioTech startup, extended its Series A financing with €29.3 million from the British Business Bank. This is the bank's largest life sciences investment to date. The total Series A now reaches €127.8 million. Alchemab will use the funds to expand its antibody dataset from 500 million to one billion sequences and advance clinical candidates.
Level
Hype check
Tap to vote and see what everyone thinks.
